CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of chronic disease
3.4.1.2. Rise in adoption of personalized medicines
3.4.1.3. Technological advancements in multiplexed products
3.4.2. Restraints
3.4.2.1. Lack of skilled labor/healthcare professionals
3.4.3. Opportunities
3.4.3.1. Rise in R&D activities
CHAPTER 4: MULTIPLEX ASSAY MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Protein Based Multiplex Assays
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Nucleic Acid-Based Multiplex Assays
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Cell-based Multiplex Assays
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: MULTIPLEX ASSAY MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Reagents and Consumables
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Instruments and Accessories
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Software and Services
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: MULTIPLEX ASSAY MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Clinical Diagnostics
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Research and Development
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Companion Diagnostics
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: MULTIPLEX ASSAY MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospitals
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Clinical Laboratories
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Research Institutes
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Pharmaceutical and Biotechnology Companies
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
CHAPTER 8: MULTIPLEX ASSAY MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Type
8.2.3. Market size and forecast, by Product
8.2.4. Market size and forecast, by Application
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Type
8.2.6.1.2. Market size and forecast, by Product
8.2.6.1.3. Market size and forecast, by Application
8.2.6.1.4. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Type
8.2.6.2.2. Market size and forecast, by Product
8.2.6.2.3. Market size and forecast, by Application
8.2.6.2.4. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by Type
8.2.6.3.2. Market size and forecast, by Product
8.2.6.3.3. Market size and forecast, by Application
8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Type
8.3.3. Market size and forecast, by Product
8.3.4. Market size and forecast, by Application
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by Type
8.3.6.1.2. Market size and forecast, by Product
8.3.6.1.3. Market size and forecast, by Application
8.3.6.1.4. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by Type
8.3.6.2.2. Market size and forecast, by Product
8.3.6.2.3. Market size and forecast, by Application
8.3.6.2.4. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by Type
8.3.6.3.2. Market size and forecast, by Product
8.3.6.3.3. Market size and forecast, by Application
8.3.6.3.4. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Type
8.3.6.4.2. Market size and forecast, by Product
8.3.6.4.3. Market size and forecast, by Application
8.3.6.4.4. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Type
8.3.6.5.2. Market size and forecast, by Product
8.3.6.5.3. Market size and forecast, by Application
8.3.6.5.4. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by Type
8.3.6.6.2. Market size and forecast, by Product
8.3.6.6.3. Market size and forecast, by Application
8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Type
8.4.3. Market size and forecast, by Product
8.4.4. Market size and forecast, by Application
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by Type
8.4.6.1.2. Market size and forecast, by Product
8.4.6.1.3. Market size and forecast, by Application
8.4.6.1.4. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by Type
8.4.6.2.2. Market size and forecast, by Product
8.4.6.2.3. Market size and forecast, by Application
8.4.6.2.4. Market size and forecast, by End User
8.4.6.3. Australia
8.4.6.3.1. Market size and forecast, by Type
8.4.6.3.2. Market size and forecast, by Product
8.4.6.3.3. Market size and forecast, by Application
8.4.6.3.4. Market size and forecast, by End User
8.4.6.4. India
8.4.6.4.1. Market size and forecast, by Type
8.4.6.4.2. Market size and forecast, by Product
8.4.6.4.3. Market size and forecast, by Application
8.4.6.4.4. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Type
8.4.6.5.2. Market size and forecast, by Product
8.4.6.5.3. Market size and forecast, by Application
8.4.6.5.4. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by Type
8.4.6.6.2. Market size and forecast, by Product
8.4.6.6.3. Market size and forecast, by Application
8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Type
8.5.3. Market size and forecast, by Product
8.5.4. Market size and forecast, by Application
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by Type
8.5.6.1.2. Market size and forecast, by Product
8.5.6.1.3. Market size and forecast, by Application
8.5.6.1.4. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Market size and forecast, by Type
8.5.6.2.2. Market size and forecast, by Product
8.5.6.2.3. Market size and forecast, by Application
8.5.6.2.4. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Market size and forecast, by Type
8.5.6.3.2. Market size and forecast, by Product
8.5.6.3.3. Market size and forecast, by Application
8.5.6.3.4. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Market size and forecast, by Type
8.5.6.4.2. Market size and forecast, by Product
8.5.6.4.3. Market size and forecast, by Application
8.5.6.4.4. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. Thermo Fisher Scientific Inc.
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.2. Illumina Inc.
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.3. Randox Laboratories Limited
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.4. Bio-Rad Laboratories, Inc.
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.4.7. Key strategic moves and developments
10.5. Abcam plc.
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.6. Qiagen N.V
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.6.7. Key strategic moves and developments
10.7. Becton, Dickinson and Company
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.7.7. Key strategic moves and developments
10.8. Seegene Inc
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. MESO SCALE DIAGNOSTICS, LLC
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.10. Diasorin S.p.A.
10.10.1. Company overview
10.10.2. Key executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
10.10.7. Key strategic moves and developments
| ※参考情報 マルチプレックスアッセイは、一度の実験で複数のバイオマーカーや分子を同時に検出、定量する技術です。この技術は、特定の疾患の診断や治療効果の評価、バイオマーカーの同時測定に非常に有用です。 マルチプレックスアッセイにはいくつかの種類があります。最も一般的なものの一つは、マルチプレックスPCR（ポリメラーゼ連鎖反応）です。これは複数のDNAまたはRNAのターゲットを同時に増幅する技術で、特に感染症の病原体を検出する際に利用されます。また、ビーズベースのアッセイも広く使われており、特定の抗体で覆われたビーズを用いて、サンプル内の複数のアナライト（分析物）を同時に検出する方法です。さらに、フルオロフォアを用いたマルチプレックスELISA（酵素連結免疫吸着測定法）もあります。これは色素を標識した抗体を使用することで、多数の異なるタンパク質を同時に定量することができます。 これらの技術は、さまざまな用途に利用されます。医学分野では、特にがん診断や感染症のスクリーニングで重要です。同時に複数のマーカーを測定することで、より精密な診断が可能となり、患者ごとの治療方針を最適化する手助けになります。例えば、がんに関しては、腫瘍マーカーの異なる組み合わせを測定することで、病状の進行や治療への反応を評価できる場合があります。 さらに、マルチプレックスアッセイは、疫学研究や公衆衛生の分野でも活用されています。大量のサンプルを迅速に分析することができるため、感染症の流行や新たなバイオマーカーの発見に寄与します。環境モニタリングにも使用され、環境中の複数の汚染物質を同時に測定することで、大気水質の評価や食品安全検査を行うことが可能です。 マルチプレックスアッセイの関連技術には、多重化フローサイトメトリーや質量分析が含まれます。フローサイトメトリーは、細胞や微小粒子にフルオロフォアを結合させ、それらを流れの中で計測することで、同時に多くのパラメータを解析します。質量分析は、分子の質量を測定することで、同時に複数の化合物の定量を行います。これらの技術は、マルチプレックスアッセイと組み合わせることで、より高い精度と信頼性を持つデータを提供します。 また、マルチプレックスアッセイは、技術の進化とともに自動化が進んでいます。ロボティクス技術やAI（人工知能）の導入により、解析スピードの向上やエラーの低減が実現しています。これにより、研究者や臨床医は、より多くのデータを効率的に処理できるようになっています。 今後、マルチプレックスアッセイは、個別化医療の発展や、さらなる技術革新に貢献すると考えられています。新しいバイオマーカーの発見や、その解析において、マルチプレックスアッセイはますます重要な役割を果たすでしょう。この技術の進展により、診断法の革新や治療法の開発が期待されています。 このように、マルチプレックスアッセイは、バイオサイエンスのさまざまな分野で重要なツールとなっており、その可能性はますます広がっています。それに伴って、より高度な分析が求められ、研究や産業における基盤技術としての地位を確立しています。今後のさらなる発展により、さまざまな分野での適用が見込まれており、早期の疾病発見や効果的な治療方法の確立に寄与することが期待されています。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
